Table 4.
MS | HSP/HA | Unadjusted β (95%CI) |
P-value | Adjusted β (95%CI) |
P-value | |
---|---|---|---|---|---|---|
25(OH)D | 77.5 ± 28.9 | 70 ± 26.2 | −7.5 (15.9, 1.0) | 0.08 | −7.5 (15.9, 1.0) | 0.08 |
1,25(OH) 2D | 139.8 ± 55.9 | 129.0 ± 36.2 | −10.8 (−25.4, 3.9) | 0.2 | −10.8 (−25.4, 3.9) | 0.2 |
PTH | 3.7 ± 2.0 | 4,7 ± 2.0 | 1.0 (0.4,1.6) | 0.002 | 0.17 (−0.6,1.0) | 0.7* |
iCa | 1.3 ± 0.1 | 1.3 ± 0.1 | 0.0 (−0.01, 0.01) | 0.8 | 0.0 (−0.01, 0.01) | 0.8 |
Phosphate | 1.1 ± 0.2 | 1.0 ± 0.2 | −0.1 (−1.2, 0.02) | 0.009 | 0.0 (−0.1, 0.1) | 0.8** |
DBP | 4.2 ± 0.6 | 4.3 ± 0.8 | 0.1 (−0.1, 0.3) | 0.5 | 0.1 (−0.1, 0.3) | 0.5 |
Creat | 67.7 ± 12.8 | 70.6 ± 14.4 | 2.9 (−1.3, 7.0) | 0.2 | 2.9 (−1.3, 7.0) | 0.2 |
bALP | 23.4 ± 8.2 | 25.0 ± 6.1 | 1.6 (−0.6, 3.8) | 0.2 | 1.6 (−0.6, 3.8) | 0.2 |
NTX | 46.8 ± 20.9 | 54.1 ± 36.3 | 7.3 (−1.7, 16.2) | 0.1 | 7.3 (−1.7, 16.2) | 0.1 |
Total Ca | 2.4 ± 0.1 | 2.4 ± 0.1 | 0.0 (−0.01, 0.01) | 0.9 | 0.0 (−0.01, 0.01) | 0.9 |
Albumin | 44.9 ± 2.4 | 45.3 ± 2.5 | 0.4 (−0.4, 1.1) | 0.3 | 0.4 (−0.4, 1.1) | 0.3 |
TSH | 1.3 ± 0.7 | 1.3 ± 0.6 | 0.0 (−0.2, 0.2) | 0.9 | −0.0 (−0.2, 0.2) | 0.9 |
Some variables have missing values due to technical errors (number of missing patients in parentheses): iCalcium (2), total Ca (2), phosphate (3), creatinin (3), albumin (3), thyroid stimulating hormone (TSH) and NTX (2) from MS patients and PTH (1), iCa (1), total Ca (1), phosphate (2), albumin (1) and NTX (2) from HA/HSP patients
Abbreviations: 25(OH)D 25-hydroxyvitamin D, 1,25(OH) 2 D 1,25-dihydroxyvitamin D (active vitamin D metabolite), PTH parathyroid hormone, iCa ionized calcium, DBP vitamin D binding protein, bALP bone specific alkaline phosphatase, NTX cross linked N-terminal telopeptide of type 1 collagen, Ca calcium, TSH thyroid stimulating hormone
*Adjusted for corticosteroid use, disease duration and alcohol use
**Adjusted for corticosteroid and BMI